Montreal-based GMP pharmaceutical laboratory CCrest Labs, an R&D collaborator of Ontario-based mushroom company Red Light Holland Corp. (OTCQB:TRUFF), has received a fifth psilocybin import permit to its Canadian controlled drugs and substances dealer’s license.
The new permit enables CCrest to import 5kg of Red Light Holland’s natural psilocybin truffles grown on its farm in the Netherlands.
Business Focus: Psychedelic Projects
Red Light produces, grows and sells both functional mushrooms and home-grow kits in North America and Europe as well as premium psilocybin truffles to the recreational market in the Netherlands.
The company’s collaboration with CCrest Labs has spawned a dehydrated, homogenized psilocybin microdosing product from its Dutch naturally-occurring psilocybin truffles.
These natural psilocybin microdosing products have passed four months of tests, confirming the stability of psilocybin. The results followed the completion of a certificate of analysis confirming the products are medical-grade quality, free of any pesticides, bio-contaminants or heavy metals, reported Red Light.
The new, larger psilocybin truffles import is expected to allow the company to further its R&D program, specifically on developing clinical-grade psilocybin drug products extracted from Red Light Holland’s naturally occurring psilocybin truffles, with the help of newly-hired consultant firm MDXX-class molecules developer PharmAla Biotech Holdings (OTC:MDXXF).
This one-year collaboration will seek regulatory approval to sell the aforementioned standardized doses of natural psilocybin products to clinical trials, government-approved access programs …